Acorah Software Products - Accounts Production 19.2.350 false true 31 October 2024 1 November 2023 false true No description of principal activity 1 November 2024 31 October 2025 31 October 2025 SC677513 Mr Jonathan Dempsey iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC677513 2024-10-31 SC677513 2025-10-31 SC677513 2024-11-01 2025-10-31 SC677513 frs-core:CurrentFinancialInstruments 2025-10-31 SC677513 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 SC677513 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 SC677513 frs-bus:Micro-entities 2024-11-01 2025-10-31 SC677513 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 SC677513 frs-bus:Director1 2024-11-01 2025-10-31 SC677513 2023-10-31 SC677513 2024-10-31 SC677513 2023-11-01 2024-10-31 SC677513 frs-core:CurrentFinancialInstruments 2024-10-31
Registered number: SC677513
Pathway Biopharma Limited
Unaudited Financial Statements
For The Year Ended 31 October 2025
Egia Financial Limited
Balance Sheet
Registered number: SC677513
2025 2024
£ £
Fixed assets 2,227 2,843
Current assets 32,520 50,302
Prepayments and accrued income 279 110
Creditors: Amounts Falling Due Within One Year (7,821 ) (14,273 )
NET CURRENT ASSETS 24,978 36,139
TOTAL ASSETS LESS CURRENT LIABILITIES 27,205 38,982
Accruals and deferred income (28 ) (194 )
NET ASSETS 27,177 38,788
CAPITAL AND RESERVES 27,177 38,788

Notes

1. General Information
Pathway Biopharma Limited is a private company, limited by shares, incorporated in Scotland, registered number SC677513 . The registered office is 29 Morningside Grove, Edinburgh, EH10 5PX.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Jonathan Dempsey
Director
30/06/2026